Part IPublic NoticePublished: April 30, 2022

Waivers for New Substances Information Requirements

Canada Gazette, Part I, Volume 156, Number 18: GOVERNMENT NOTICES

On April 30, 2022, Environment and Climate Change Canada announced that it granted waivers under the Canadian Environmental Protection Act, 1999 allowing certain applicants to omit specified test data when seeking to import or manufacture new living organisms or chemical substances. The waivers affect named universities and companies and reduce required testing (e.g. some ecological, antibiotic susceptibility, hydrolysis and mutagenicity data), which can speed development but means regulators may assess some submissions with less information.

Published
April 30, 2022
Department
Unavailable
Section
DEPARTMENT OF THE ENVIRONMENT
Comment deadline
Unavailable
Effective date
Unavailable
Publication part
Part I

Summary

Summary#

On April 30, 2022, the Department of the Environment published notices that it granted waivers of some information requirements under the Canadian Environmental Protection Act, 1999. The waivers let several universities and companies provide fewer test results when applying to import or manufacture certain new living organisms or chemical substances.

What it does#

  • For living organisms, the department waived requirements for some test data that would normally show effects on aquatic and terrestrial plants and animals, and for tests of antibiotic susceptibility. Waivers were granted to institutions including McMaster University, Queen’s University, University Health Network, and Vertex Pharmaceuticals Incorporated.
  • For chemical substances, the department waived specific testing requirements such as hydrolysis rate as a function of pH, vapour pressure, and certain in vivo mammalian mutagenicity tests. Waivers were granted to companies including 3M Canada Company, Chemical Compliance CA Inc., and Piramal Healthcare (Canada) Limited.
  • The notices say these waivers are granted case-by-case and in consultation with the Minister of Health.

Who's affected#

  • The named research institutions and companies listed above are directly affected because they received the waivers.
  • More broadly, anyone who proposes to import or manufacture a living organism or a chemical substance that is not on the Domestic Substances List and who seeks a similar waiver could be affected, since waiver decisions change what information applicants must provide.
  • The notices do not make clear how often similar waivers will be granted to other parties in future cases.

Why it matters#

  • Waivers reduce the amount of testing data applicants must provide. That can speed research or product development and lower testing costs for the organizations involved.
  • It also means regulators will be making assessments with less information in some cases. That could affect how much safety or environmental data is publicly available about a new organism or substance.
  • The notices note that about 450 regulatory declarations are submitted each year and around 100 waivers are granted annually for chemicals, polymers and living organisms. For more information, the notices point readers to the waivers page on the New Substances website.

Key topics

Canadian Environmental Protection Act, 1999CEPADomestic Substances ListDSLNew Substances ProgramEnvironment and Climate Change CanadaHealth CanadaMcMaster UniversityQueen's UniversityUniversity Health NetworkVertex Pharmaceuticals Incorporated3M Canada CompanyChemical Compliance CA Inc.Piramal Healthcare (Canada) Limitedantibiotic susceptibility tests

Source: Canada Gazette

Official source